Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.57 |
| ▸ | HMGCR | P04035 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31520021 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 | |
| SCHEMBL31520016 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 | |
| SCHEMBL31520020 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 | |
| SCHEMBL31520019 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 | |
| SCHEMBL30966140 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 | |
| SCHEMBL28584660 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 | |
| SCHEMBL31520015 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 | |
| SCHEMBL31520018 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 | |
| SCHEMBL31520017 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 | |
| SCHEMBL29242822 | 0.98 | PTPN7 (0.61) | PTPN7HMGCRLMNAMAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4183391-A1 | PHARMACEUTICAL COMPOSITION AND USE THEREOF | Shenzhen Salubris Pharmaceuticals Co., Ltd. (CN) | 2023-05-24 | — | — | EP | claimed |
| US-20180263991-A1 | COMPLEXES AND SALTS OF DIHYDROPYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN PHARMACEUTICALS | SUNSHINE LAKE PHARMA CO., LTD (CN) | 2018-09-20 | — | — | US | claimed |
| CN-122011115-A | Cyclic antibacterial peptide derivative and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2026-05-12 | — | — | CN | disclosed |
| US-20250326720-A1 | CAREBASTINE SALT AND USE OF SAME | CHENGDU SHIBEIKANG BIOMEDICAL TECH CO LTD (CN) | 2025-10-23 | — | — | US | disclosed |
| US-12391647-B2 | Benzamide compound and preparation method, use, and pharmaceutical composition thereof | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2025-08-19 | — | — | US | disclosed |
| CN-119912668-A | Synthesis of linear aliphatic polyesters | 丰益国际有限公司 | 2025-05-02 | — | — | CN | disclosed |
| EP-4520752-A1 | CAREBASTINE SALT AND USE THEREOF | Chengdu Shibeikang Biomedical Technology Co., Ltd. (CN) | 2025-03-12 | — | — | EP | disclosed |
| CN-118831183-A | Stabilized compositions of radionuclides and uses thereof | 瑞择生物公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-118265536-A | Engineered antibacterial peptides and uses thereof | 肽逻辑公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-111936502-B | Heterobicyclic carboxylic acids and salts thereof | 深圳市原力生命科学有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118103078-A | Stabilized compositions of radionuclides and uses thereof | 瑞择生物公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-112312896-A | Dosage forms comprising a living biotherapeutic product | 4D制药研究有限公司 | 2021-02-02 | — | — | CN | disclosed |
| EP-3253751-B1 | COMPLEXES AND SALTS OF DIHYDROPYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN PHARMACEUTICALS | SUNSHINE LAKE PHARMA CO LTD (CN) | 2020-12-09 | — | — | EP | disclosed |
| EP-3747866-A1 | BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2020-12-09 | — | — | EP | disclosed |
| US-20200121690-A1 | SALT OF SUBSTITUTED UREA DERIVATIVE AND USE THEREOF IN MEDICINE | NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED (CN) | 2020-04-23 | — | — | US | disclosed |
| CN-110582507-A | Engineered antimicrobial amphiphilic peptides and methods of use | 肽逻辑公司 | 2019-12-17 | — | — | CN | disclosed |
| US-10098889-B2 | Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2018-10-16 | — | — | US | disclosed |
| US-20180263991-A1 | COMPLEXES AND SALTS OF DIHYDROPYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN PHARMACEUTICALS | SUNSHINE LAKE PHARMA CO., LTD (CN) | 2018-09-20 | — | — | US | disclosed |
| EP-0980016-B1 | ALIGNING AGENT FOR LIQUID CRYSTAL | NISSAN CHEMICAL IND LTD (JP) | 2008-09-24 | — | — | EP | disclosed |
| EP-0980016-A1 | ALIGNING AGENT FOR LIQUID CRYSTAL | Nissan Chemical Industries, Ltd. (JP) | 2000-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200121690-A1 | SALT OF SUBSTITUTED UREA DERIVATIVE AND USE THEREOF IN MEDICINE | JAK1, SLC14A1, REN | PTPN7 96/4885HMGCR 3406/4885LMNA 4446/4885 |
| US-12391647-B2 | Benzamide compound and preparation method, use, and pharmaceutical composition thereof | JAK2, STAT3, STAT5A | PTPN7 1672/4885HMGCR 4148/4885LMNA 2434/4885 |
| US-20180263991-A1 | COMPLEXES AND SALTS OF DIHYDROPYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN PHARMACEUTICALS | TPMT, SLC10A1, HPRT1 | PTPN7 901/4885HMGCR 36/4885LMNA 1560/4885 |
| US-20250326720-A1 | CAREBASTINE SALT AND USE OF SAME | HRH4, SLC7A1, HRH1 | PTPN7 4173/4885HMGCR 902/4885LMNA 4624/4885 |
| US-10098889-B2 | Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals | TPMT, SLC10A1, HPRT1 | PTPN7 901/4885HMGCR 36/4885LMNA 1560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.